Protocol FCR001A2301 - A Randomized, Controlled, Multi-center, Safety and Efficacy Study of FCR001 Cell-Based Therapy Relative to a Tacrolimus and Mycophenolate-Based Regimen in De Novo Living Donor Renal Transplant Recipients, and Safety in FCR001 Donors